Concepedia

Giovanni Giurdanella

GG

Statistics

Publications

39

Citations

1.5K

H-Index

25

Active since

2005

Affiliations

University of Catania(Current)

Università degli Studi di Enna Kore

University of Ragusa

Giovanni Giurdanella is an author at University of Catania specializing in medicine, ophthalmology, and cell signaling.

Top concepts

MedicineOphthalmologyCell BiologyCell SignalingVascular BiologyPharmacologyDiabetesInflammationSignal TransductionDiabetic Retinopathy

Publications per year

2005–2023

39

Publications

39

Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia

Tibor Štark, Jana Kučerová, Fabio Arturo Iannotti et al. · Neuropharmacology · 2018 · 88 citations

Psychotropic Medication, Psychopharmacology, Neuropsychiatry +16

P2X7 receptor antagonism: Implications in diabetic retinopathy

Chiara Bianca Maria Platania, Giovanni Giurdanella, Luisa Di Paola et al. · Biochemical Pharmacology · 2017 · 77 citations

Molecular Pharmacology, Diabetic Retinopathy, Ocular Disease +5

Role of phospholipases A2 in diabetic retinopathy: In vitro and in vivo studies

Gabriella Lupo, Carla Motta, Giovanni Giurdanella et al. · Biochemical Pharmacology · 2013 · 76 citations

Diabetic Retinopathy, Ocular Disease, Signal Transduction +9

Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway

Francesca Lazzara, Annamaria Fidilio, Chiara Bianca Maria Platania et al. · Biochemical Pharmacology · 2019 · 73 citations

Inflammation, Ocular Disease, Signal Transduction +13

Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway

Giovanni Giurdanella, Carmelina Daniela Anfuso, Melania Olivieri et al. · Biochemical Pharmacology · 2015 · 69 citations

Inflammation, Diabetic Retinopathy, Pla2/cox-2/vegf-a Pathway +11

1–5 of 39